Form D · Business Services
JINZANGHUANG TIBET PHARMACEUTICALS, INC.
Shandong Province, F4 · CIK 0000910832
Offering snapshot reported Aug 21, 2012 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 31, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2012 | Initial | $1,000,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-183001
Source: Form D, filed Aug 21, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Xiaosong Bai | Director |
| Xue Bangyi | Director, Executive |
| Vincent De Filippo | Director |
| Eva Deng | Director, Executive |
| Min Liu | Director |
| Dehai Luan | Director |
| Shuxiang Wang | Director, Executive |
Issuer details
Industry: Business Services (See others in industry)
Address:
Leling Economic Development Zone Kaiyuan East Blvd., Dezhou
Shandong Province, F4, 253600
Shandong Province, F4, 253600